Baldini, G.M.; Mastrorocco, A.; Sciorio, R.; Palini, S.; Dellino, M.; Cascardi, E.; Cazzato, G.; Malvasi, A.; Baldini, D.; Trojano, G.
Inadvertent Administration of 72 µg of Follitropin-Δ for Three Consecutive Days Does Not Appear to Be Dangerous for Poor Responders: A Case Series. J. Clin. Med. 2023, 12, 5202.
https://doi.org/10.3390/jcm12165202
AMA Style
Baldini GM, Mastrorocco A, Sciorio R, Palini S, Dellino M, Cascardi E, Cazzato G, Malvasi A, Baldini D, Trojano G.
Inadvertent Administration of 72 µg of Follitropin-Δ for Three Consecutive Days Does Not Appear to Be Dangerous for Poor Responders: A Case Series. Journal of Clinical Medicine. 2023; 12(16):5202.
https://doi.org/10.3390/jcm12165202
Chicago/Turabian Style
Baldini, Giorgio Maria, Antonella Mastrorocco, Romualdo Sciorio, Simone Palini, Miriam Dellino, Eliano Cascardi, Gerardo Cazzato, Antonio Malvasi, Domenico Baldini, and Giuseppe Trojano.
2023. "Inadvertent Administration of 72 µg of Follitropin-Δ for Three Consecutive Days Does Not Appear to Be Dangerous for Poor Responders: A Case Series" Journal of Clinical Medicine 12, no. 16: 5202.
https://doi.org/10.3390/jcm12165202
APA Style
Baldini, G. M., Mastrorocco, A., Sciorio, R., Palini, S., Dellino, M., Cascardi, E., Cazzato, G., Malvasi, A., Baldini, D., & Trojano, G.
(2023). Inadvertent Administration of 72 µg of Follitropin-Δ for Three Consecutive Days Does Not Appear to Be Dangerous for Poor Responders: A Case Series. Journal of Clinical Medicine, 12(16), 5202.
https://doi.org/10.3390/jcm12165202